1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies
    Meeting Abstract

    Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Caleb, B.; Darman, R.; Fekkes, P.; Karr, C.; Keaney, G. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparison of peripheral blood stem cells (PBSC) to bone marrow (BM) for T-replete HLA-haploidentical donor transplantation using post-transplant cyclophosphamide
    Meeting Abstract

    Bashey, A.; Zhang, M.; McCurdy, S. R.; Ciurea, S. O.; St Martin, A.; Anasetti, C.; Argall, T.; Fasan, O. O.; Gaballa, S.; Hamadani, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Pembrolizumab in combination with pomalidomide and dexamethasone for relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Badros, A. Z.; Hyjek, E.; Ma, N.; Lesokhin, A. M.; Rapoport, A. P.; Kocoglu, M. H.; Lederer, E.; Philip, S.; Lesho, P.; Johnson, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory or relapsed peripheral T-cell lymphoma: Analysis of 1020 cases registered in the prospective T-cell project
    Meeting Abstract

    Bellei, M.; Foss, F. M.; Horwitz, S. M.; Marcheselli, L.; Kim, W. S.; Cabrera, M. E.; Dlouhy, I.; Nagler, A.; Advani, R. H.; Pesce, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Vadastuximab talirine monotherapy in older patients with treatment naive CD33-positive acute myeloid leukemia (AML)
    Meeting Abstract

    Bixby, D. L.; Stein, A. S.; Fathi, A. T.; Kovacsovics, T. J.; Levy, M. Y.; Erba, H. P.; Lancet, J. E.; Jillella, A. P.; Ravandi, F.; Walter, R. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Improved survival in AL amyloidosis: A population-based study on 1,430 patients diagnosed in Sweden 1995-2013
    Meeting Abstract

    Weiss, B. M.; Lund, S. H.; Bjorkholm, M.; Cohen, A. D.; Dember, L.; Landgren, O.; Kristinsson, S. Y.
    Blood (2016)

    Fulltext@MSK | Save
  • Results of a phase Ib study of venetoclax plus R- or G-CHOP in patients with B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Zelenetz, A. D.; Salles, G. A.; Mason, K. D.; Casulo, C.; Le Gouill, S.; Sehn, L. H.; Tilly, H.; Cartron, G.; Chamuleau, M. E. D.; Goy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Astarabine, a novel leukemia-targeted cytarabine composition allows, for the first time, the delivery of high cytarabine doses for older or unfit patients with acute leukemia. Results of an ongoing phase I/IIa study
    Meeting Abstract

    Zuckerman, T.; Gengrinovitch, S.; Ben-Yakar, R.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Horowitz, N. A.; Nudelman, O.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039)
    Meeting Abstract

    Ansell, S.; Gutierrez, M. E.; Shipp, M. A.; Gladstone, D.; Moskowitz, A.; Borello, I.; Popa-Mckiver, M.; Farsaci, B.; Zhu, L.; Lesokhin, A. M.; more...
    Blood (2016)

    Fulltext@MSK | Save